Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 8.4B
Gross Profit 5.6B 67.46%
Operating Income 2.3B 28.12%
Net Income 2.3B 27.99%

Balance Sheet Metrics

Total Assets 18.7B
Total Liabilities 2.2B
Shareholders Equity 16.5B
Debt to Equity 0.13

Cash Flow Metrics

Operating Cash Flow 2.7B
Free Cash Flow 1.3B

Revenue & Profitability Trend

Intuitive Surgical Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 8.4B 7.1B 6.2B 5.7B 4.4B
Cost of Goods Sold 2.7B 2.4B 2.0B 1.8B 1.5B
Gross Profit 5.6B 4.7B 4.2B 4.0B 2.9B
Operating Expenses 3.3B 3.0B 2.6B 2.1B 1.8B
Operating Income 2.3B 1.8B 1.6B 1.8B 1.0B
Pre-tax Income 2.7B 2.0B 1.6B 1.9B 1.2B
Income Tax 336.3M 141.6M 262.4M 162.2M 140.2M
Net Income 2.3B 1.8B 1.3B 1.7B 1.1B
EPS (Diluted) - $5.03 $3.65 $4.66 $2.94

Income Statement Trend

Intuitive Surgical Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 7.1B 7.9B 6.3B 5.8B 6.6B
Non-Current Assets 11.6B 7.6B 6.7B 7.7B 4.5B
Total Assets 18.7B 15.4B 13.0B 13.6B 11.2B
Liabilities
Current Liabilities 1.7B 1.7B 1.4B 1.1B 965.2M
Non-Current Liabilities 468.3M 385.5M 439.3M 453.7M 444.6M
Total Liabilities 2.2B 2.0B 1.9B 1.6B 1.4B
Equity
Total Shareholders Equity 16.5B 13.4B 11.1B 12.0B 9.8B

Balance Sheet Composition

Intuitive Surgical Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 2.3B 1.8B 1.3B 1.7B 1.1B
Operating Cash Flow 2.7B 1.8B 1.6B 2.3B 1.7B
Investing Activities
Capital Expenditures -1.1B -1.1B -532.4M -339.5M -341.5M
Investing Cash Flow -3.3B -360.1M 1.4B -2.5B -940.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -278.5M -583.9M -2.8B -233.5M -394.5M
Free Cash Flow 1.3B 749.6M 958.4M 1.7B 1.1B

Cash Flow Trend

Intuitive Surgical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 75.42
Forward P/E 65.53
Price to Book 10.79
Price to Sales 21.18
PEG Ratio 65.53

Profitability Ratios

Profit Margin 28.41%
Operating Margin 25.66%
Return on Equity 15.96%
Return on Assets 8.84%

Financial Health

Current Ratio 4.98
Debt to Equity 0.00
Beta 1.68

Per Share Data

EPS (TTM) $6.83
Book Value per Share $47.73
Revenue per Share $24.47

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
isrg 184.6B 75.42 10.79 15.96% 28.41% 0.00
Becton, Dickinson 48.6B 32.89 1.93 5.89% 7.18% 76.34
Alcon 42.8B 38.45 1.95 5.23% 11.28% 23.63
ResMed 37.3B 28.60 6.73 25.81% 26.15% 15.14
West Pharmaceutical 16.0B 34.96 5.96 17.42% 16.13% 11.46
Baxter International 15.4B 133.76 2.17 -3.51% -5.20% 146.14

Financial data is updated regularly. All figures are in the company's reporting currency.